- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-403/16: Action brought on 28 July 2016 — Stada Arzneimittel v EUIPO — Vivatech (Immunostad)
ECLI:EU:UNKNOWN:62016TN0403
62016TN0403
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
12.9.2016
EN
Official Journal of the European Union
C 335/51
(Case T-403/16)
(2016/C 335/68)
Language in which the application was lodged: German
Parties
Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: R. Kaase and J. Plate, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Vivatech (Paris, France)
Details of the procedure before EUIPO
Proprietor of the mark at issue: the applicant
Mark at issue: EU word mark ‘Immunostad’ — EU trade mark No 9 552 225
Proceedings before EUIPO: invalidity proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 19 April 2016 in Case R 863/2015–5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—order EUIPO to bear the costs, including the costs of the appeal.
Pleas in law
—Infringement of Article 8(1)(b) of Regulation No 207/2009;
—Infringement of Article 75 of Regulation No 207/2009.